Could this drug stop the body from attacking itself in diabetes?
NCT ID NCT03782636
Summary
This study is testing if a drug called aldesleukin can help children and young adults recently diagnosed with type 1 diabetes keep producing their own insulin. It aims to calm the immune system's mistaken attack on insulin-making cells. The trial involves 41 participants who will receive either the drug or a placebo to see if it can preserve the body's remaining insulin production.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, United Kingdom
-
Bristol Royal Hospital for Children
Bristol, United Kingdom
-
Nottingham Children's Hospital
Nottingham, United Kingdom
-
Oxford Children's Hospital
Oxford, Oxfordshire, OX3 9DU, United Kingdom
-
The Great North Children's Hospital
Newcastle upon Tyne, United Kingdom
Conditions
Explore the condition pages connected to this study.